Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2013

Open Access 01-12-2013 | Case report

A novel missense mutation in the CLCN7 gene linked to benign autosomal dominant osteopetrosis: a case series

Authors: Ban Mousa Rashid, Nawshirwan Gafoor Rashid, Ansgar Schulz, Georgia Lahr, Beston Faiek Nore

Published in: Journal of Medical Case Reports | Issue 1/2013

Login to get access

Abstract

Introduction

Osteopetrosis is a rare inherited genetic disease characterized by sclerosis of the skeleton. The absence or malfunction of osteoclasts is found to be strongly associated with the disease evolution. Currently, four clinically distinct forms of the disease have been recognized: the infantile autosomal recessive osteopetrosis, the malignant and the intermediate forms, and autosomal dominant osteopetrosis, type I and type II forms. The autosomal recessive types are the most severe forms with symptoms in very early childhood, whereas the autosomal dominant classes exhibit a heterogeneous trait with milder symptoms, often at later childhood or adulthood.

Case presentation

Case 1 is the 12-year-old daughter (index patient) of an Iraqi-Kurdish family who, at the age of eight years, was diagnosed clinically to have mild autosomal dominant osteopetrosis. Presently, at 12-years old, she has severe complications due to the disease progression. In addition, the same family previously experienced the death of a female child in her late childhood. The deceased child had been misdiagnosed, at that time, with thalassemia major. In this report, we extended our investigation to identify the type of the inheritance patterns of osteopetrosis using molecular techniques, because consanguineous marriages exist within the family history. We have detected one heterozygous mutation in exon 15 of the Chloride Channel 7 gene in the index patient (Case 1), whereas other mutations were not detected in the associated genes TCIRG1, OSTM1, RANK, and RANKL. The missense mutation (C GG>T GG) located in exon 15 (c.1225C>T) of the Chloride Channel 7 gene changed the amino acid position 409 from arginine to tryptophan (p.R409W, c.1225C>T).
Case 2 is the 16-year-old son (brother of the index patient) of the same family who was diagnosed clinically with mild autosomal dominant osteopetrosis. We have identified the same heterozygous mutation in exon 15 of the Chloride channel 7 gene in this patient (Case 2). The missense mutation (C GG>T GG) located in exon 15 (c.1225C>T) of the Chloride channel 7 gene changed the amino acid position 409 from arginine to tryptophan (p.R409W, c.1225C>T).
In addition to the clinical diagnosis of both cases, the missense mutation we identified in one allele of the Chloride channel 7 gene could be linked to autosomal dominant osteopetrosis-II because the symptoms appear in late childhood or adolescence.

Conclusion

In this family, the molecular diagnosis was confirmed after identification of the same mutation in the older son (sibling). Furthermore, we detected that the father and his brother (the uncle) are carriers of the same mutation, whereas the mother and her sister (the aunt) do not carry any mutation of the Chloride channel 7 gene. Thus, the disease penetrance is at least 60% in the family. The mother and father are cousins and a further consanguineous marriage between the aunt and the uncle is not recommended because the dominant allele of the Chloride channel 7 gene will be transferred to the progeny. However, a similar risk is also expected following a marriage between the uncle and an unrelated woman. The p.R409W mutation in the Chloride channel 7 gene has not yet been described in the literature and it possibly has a dominant-negative impact on the protein.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Superti-Furga A, Unger S: Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A. 2007, 143: 1-18.CrossRef Superti-Furga A, Unger S: Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A. 2007, 143: 1-18.CrossRef
4.
go back to reference Khan MN, Datta PK, Hasan MI, Hossain MA, Patwary KH, Ferdous J: Osteopetrosis. Mymensingh Med J. 2011, 20: 715-718.PubMed Khan MN, Datta PK, Hasan MI, Hossain MA, Patwary KH, Ferdous J: Osteopetrosis. Mymensingh Med J. 2011, 20: 715-718.PubMed
5.
go back to reference Balemans W, Van Wesenbeeck L, Van Hul W: A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int. 2005, 77: 263-274. 10.1007/s00223-005-0027-6.CrossRefPubMed Balemans W, Van Wesenbeeck L, Van Hul W: A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int. 2005, 77: 263-274. 10.1007/s00223-005-0027-6.CrossRefPubMed
6.
go back to reference Bollerslev J, Mosekilde L: Autosomal dominant osteopetrosis. Clin Orthop Relat Res. 1993, 294: 45-51.PubMed Bollerslev J, Mosekilde L: Autosomal dominant osteopetrosis. Clin Orthop Relat Res. 1993, 294: 45-51.PubMed
7.
go back to reference Henriksen K, Gram J, Hoegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA: Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol. 2005, 167: 1341-1348. 10.1016/S0002-9440(10)61221-7.CrossRefPubMedPubMedCentral Henriksen K, Gram J, Hoegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA: Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol. 2005, 167: 1341-1348. 10.1016/S0002-9440(10)61221-7.CrossRefPubMedPubMedCentral
8.
go back to reference Van Hul E, Gram J, Bollerslev J, Van Wesenbeeck L, Mathysen D, Andersen PE, Vanhoenacker F, Van Hul W: Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. J Bone Miner Res. 2002, 17: 1111-1117. 10.1359/jbmr.2002.17.6.1111.CrossRefPubMed Van Hul E, Gram J, Bollerslev J, Van Wesenbeeck L, Mathysen D, Andersen PE, Vanhoenacker F, Van Hul W: Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. J Bone Miner Res. 2002, 17: 1111-1117. 10.1359/jbmr.2002.17.6.1111.CrossRefPubMed
9.
go back to reference Bollerslev J, Andersen PE: Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone. 1988, 9: 7-13. 10.1016/8756-3282(88)90021-X.CrossRefPubMed Bollerslev J, Andersen PE: Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone. 1988, 9: 7-13. 10.1016/8756-3282(88)90021-X.CrossRefPubMed
10.
go back to reference Benichou OD, Laredo JD, de Vernejoul MC: Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone. 2000, 26: 87-93. 10.1016/S8756-3282(99)00244-6.CrossRefPubMed Benichou OD, Laredo JD, de Vernejoul MC: Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone. 2000, 26: 87-93. 10.1016/S8756-3282(99)00244-6.CrossRefPubMed
11.
go back to reference Albers-Schönberg HE: Röntgenbilder einer seltenen Knockenerkrankung. Munch Med Wochenschr. 1904, 51: 365-368. Albers-Schönberg HE: Röntgenbilder einer seltenen Knockenerkrankung. Munch Med Wochenschr. 1904, 51: 365-368.
12.
go back to reference Kovacs CS, Lambert RG, Lavoie GJ, Siminoski K: Centrifugal osteopetrosis: appendicular sclerosis with relative sparing of the vertebrae. Skeletal Radiol. 1995, 24: 27-29. 10.1007/BF02425942.CrossRefPubMed Kovacs CS, Lambert RG, Lavoie GJ, Siminoski K: Centrifugal osteopetrosis: appendicular sclerosis with relative sparing of the vertebrae. Skeletal Radiol. 1995, 24: 27-29. 10.1007/BF02425942.CrossRefPubMed
13.
go back to reference Duran C, Thompson CH, Xiao Q, Hartzell HC: Chloride channels: often enigmatic, rarely predictable. Annu Rev Physiol. 2010, 72: 95-121. 10.1146/annurev-physiol-021909-135811.CrossRefPubMedPubMedCentral Duran C, Thompson CH, Xiao Q, Hartzell HC: Chloride channels: often enigmatic, rarely predictable. Annu Rev Physiol. 2010, 72: 95-121. 10.1146/annurev-physiol-021909-135811.CrossRefPubMedPubMedCentral
14.
go back to reference Jentsch TJ, Stein V, Weinreich F, Zdebik AA: Molecular structure and physiological function of chloride channels. Physiol Rev. 2002, 82: 503-568.CrossRefPubMed Jentsch TJ, Stein V, Weinreich F, Zdebik AA: Molecular structure and physiological function of chloride channels. Physiol Rev. 2002, 82: 503-568.CrossRefPubMed
15.
go back to reference Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ: Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001, 104: 205-215. 10.1016/S0092-8674(01)00206-9.CrossRefPubMed Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ: Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001, 104: 205-215. 10.1016/S0092-8674(01)00206-9.CrossRefPubMed
16.
go back to reference Letizia C, Taranta A, Migliaccio S, Caliumi C, Diacinti D, Delfini E, D'Erasmo E, Iacobini M, Roggini M, Albagha OM: Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations. Calcif Tissue Int. 2004, 74: 42-46. 10.1007/s00223-002-1087-5.CrossRefPubMed Letizia C, Taranta A, Migliaccio S, Caliumi C, Diacinti D, Delfini E, D'Erasmo E, Iacobini M, Roggini M, Albagha OM: Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations. Calcif Tissue Int. 2004, 74: 42-46. 10.1007/s00223-002-1087-5.CrossRefPubMed
17.
go back to reference Frattini A, Pangrazio A, Susani L, Sobacchi C, Mirolo M, Abinun M, Andolina M, Flanagan A, Horwitz EM, Mihci E: Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res. 2003, 18: 1740-1747. 10.1359/jbmr.2003.18.10.1740.CrossRefPubMed Frattini A, Pangrazio A, Susani L, Sobacchi C, Mirolo M, Abinun M, Andolina M, Flanagan A, Horwitz EM, Mihci E: Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res. 2003, 18: 1740-1747. 10.1359/jbmr.2003.18.10.1740.CrossRefPubMed
18.
go back to reference de Vernejoul MC: Sclerosing bone disorders. Best Pract Res Clin Rheumatol. 2008, 22: 71-83. 10.1016/j.berh.2007.12.011.CrossRefPubMed de Vernejoul MC: Sclerosing bone disorders. Best Pract Res Clin Rheumatol. 2008, 22: 71-83. 10.1016/j.berh.2007.12.011.CrossRefPubMed
19.
go back to reference Zhao Q, Wei Q, He A, Jia R, Xiao Y: CLC-7: a potential therapeutic target for the treatment of osteoporosis and neurodegeneration. Biochem Biophys Res Commun. 2009, 384: 277-279. 10.1016/j.bbrc.2009.04.088.CrossRefPubMed Zhao Q, Wei Q, He A, Jia R, Xiao Y: CLC-7: a potential therapeutic target for the treatment of osteoporosis and neurodegeneration. Biochem Biophys Res Commun. 2009, 384: 277-279. 10.1016/j.bbrc.2009.04.088.CrossRefPubMed
20.
go back to reference Pangrazio A, Pusch M, Caldana E, Frattini A, Lanino E, Tamhankar PM, Phadke S, Lopez AG, Orchard P, Mihci E: Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations. Hum Mutat. 2010, 31: E1071-E1080. 10.1002/humu.21167.CrossRefPubMed Pangrazio A, Pusch M, Caldana E, Frattini A, Lanino E, Tamhankar PM, Phadke S, Lopez AG, Orchard P, Mihci E: Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations. Hum Mutat. 2010, 31: E1071-E1080. 10.1002/humu.21167.CrossRefPubMed
21.
go back to reference Waguespack SG, Hui SL, Dimeglio LA, Econs MJ: Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab. 2007, 92: 771-778.CrossRefPubMed Waguespack SG, Hui SL, Dimeglio LA, Econs MJ: Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab. 2007, 92: 771-778.CrossRefPubMed
22.
go back to reference Zhang ZL, He JW, Zhang H, Hu WW, Fu WZ, Gu JM, Yu JB, Gao G, Hu YQ, Li M, Liu YJ: Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II). J Bone Miner Metab. 2009, 27: 444-451. 10.1007/s00774-009-0051-0.CrossRefPubMed Zhang ZL, He JW, Zhang H, Hu WW, Fu WZ, Gu JM, Yu JB, Gao G, Hu YQ, Li M, Liu YJ: Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II). J Bone Miner Metab. 2009, 27: 444-451. 10.1007/s00774-009-0051-0.CrossRefPubMed
23.
go back to reference Ballet JJ, Griscelli C, Coutris C, Milhaud G, Maroteaux P: Bone-marrow transplantation in osteopetrosis. Lancet. 1977, 2: 1137-CrossRefPubMed Ballet JJ, Griscelli C, Coutris C, Milhaud G, Maroteaux P: Bone-marrow transplantation in osteopetrosis. Lancet. 1977, 2: 1137-CrossRefPubMed
24.
go back to reference Nisbet NW, Menage J, Loutit JF: Bone-marrow transplantation in osteopetrosis. Lancet. 1977, 2: 1236-CrossRefPubMed Nisbet NW, Menage J, Loutit JF: Bone-marrow transplantation in osteopetrosis. Lancet. 1977, 2: 1236-CrossRefPubMed
25.
go back to reference Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, Kim TH, Nesbit ME, Ramsay NK, Warkentin PI, Teitelbaum SL: Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med. 1980, 302: 701-708. 10.1056/NEJM198003273021301.CrossRefPubMed Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, Kim TH, Nesbit ME, Ramsay NK, Warkentin PI, Teitelbaum SL: Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med. 1980, 302: 701-708. 10.1056/NEJM198003273021301.CrossRefPubMed
26.
go back to reference Driessen GJ, Gerritsen EJ, Fischer A, Fasth A, Hop WC, Veys P, Porta F, Cant A, Steward CG, Vossen JM: Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant. 2003, 32: 657-663. 10.1038/sj.bmt.1704194.CrossRefPubMed Driessen GJ, Gerritsen EJ, Fischer A, Fasth A, Hop WC, Veys P, Porta F, Cant A, Steward CG, Vossen JM: Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant. 2003, 32: 657-663. 10.1038/sj.bmt.1704194.CrossRefPubMed
27.
go back to reference Askmyr MK, Fasth A, Richter J: Towards a better understanding and new therapeutics of osteopetrosis. Br J Haematol. 2008, 140: 597-609. 10.1111/j.1365-2141.2008.06983.x.CrossRefPubMed Askmyr MK, Fasth A, Richter J: Towards a better understanding and new therapeutics of osteopetrosis. Br J Haematol. 2008, 140: 597-609. 10.1111/j.1365-2141.2008.06983.x.CrossRefPubMed
28.
go back to reference Chen CJ, Lee MY, Hsu ML, Lien SH, Cheng SN: Malignant infantile osteopetrosis initially presenting with neonatal hypocalcemia: case report. Ann Hematol. 2003, 82: 64-67.PubMed Chen CJ, Lee MY, Hsu ML, Lien SH, Cheng SN: Malignant infantile osteopetrosis initially presenting with neonatal hypocalcemia: case report. Ann Hematol. 2003, 82: 64-67.PubMed
29.
go back to reference Waguespack SG, Hui SL, White KE, Buckwalter KA, Econs MJ: Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers. J Clin Endocrinol Metab. 2002, 87: 2212-2217. 10.1210/jc.87.5.2212.CrossRefPubMed Waguespack SG, Hui SL, White KE, Buckwalter KA, Econs MJ: Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers. J Clin Endocrinol Metab. 2002, 87: 2212-2217. 10.1210/jc.87.5.2212.CrossRefPubMed
30.
go back to reference Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Vaananen HK, Halleen JM: Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schönberg disease (type II autosomal dominant osteopetrosis). Clin Chem. 2004, 50: 883-890. 10.1373/clinchem.2003.029355.CrossRefPubMed Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Vaananen HK, Halleen JM: Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schönberg disease (type II autosomal dominant osteopetrosis). Clin Chem. 2004, 50: 883-890. 10.1373/clinchem.2003.029355.CrossRefPubMed
31.
go back to reference Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M: Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet. 2006, 43: 315-325.CrossRefPubMed Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M: Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet. 2006, 43: 315-325.CrossRefPubMed
32.
go back to reference Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T: Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet. 2001, 10: 2861-2867. 10.1093/hmg/10.25.2861.CrossRefPubMed Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T: Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet. 2001, 10: 2861-2867. 10.1093/hmg/10.25.2861.CrossRefPubMed
33.
go back to reference Weinert S, Jabs S, Supanchart C, Schweizer M, Gimber N, Richter M, Rademann J, Stauber T, Kornak U, Jentsch TJ: Lysosomal pathology and osteopetrosis upon loss of H+−driven lysosomal Cl- accumulation. Science. 2010, 328: 1401-1403. 10.1126/science.1188072.CrossRefPubMed Weinert S, Jabs S, Supanchart C, Schweizer M, Gimber N, Richter M, Rademann J, Stauber T, Kornak U, Jentsch TJ: Lysosomal pathology and osteopetrosis upon loss of H+−driven lysosomal Cl- accumulation. Science. 2010, 328: 1401-1403. 10.1126/science.1188072.CrossRefPubMed
34.
go back to reference Fotiadou A, Arvaniti M, Kiriakou V, Tsitouridis I: Type II autosomal dominant osteopetrosis: radiological features in two families containing five members with asymptomatic and uncomplicated disease. Skeletal Radiol. 2009, 38: 1015-1021. 10.1007/s00256-009-0718-6.CrossRefPubMed Fotiadou A, Arvaniti M, Kiriakou V, Tsitouridis I: Type II autosomal dominant osteopetrosis: radiological features in two families containing five members with asymptomatic and uncomplicated disease. Skeletal Radiol. 2009, 38: 1015-1021. 10.1007/s00256-009-0718-6.CrossRefPubMed
Metadata
Title
A novel missense mutation in the CLCN7 gene linked to benign autosomal dominant osteopetrosis: a case series
Authors
Ban Mousa Rashid
Nawshirwan Gafoor Rashid
Ansgar Schulz
Georgia Lahr
Beston Faiek Nore
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2013
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-7-7

Other articles of this Issue 1/2013

Journal of Medical Case Reports 1/2013 Go to the issue